About the Company :
Cipla is an Indian MNC with pharma and biotechnological products having the head quarters in Mumbai started in the year 1935. This has market capitalization of $7 billion. Company has footprints in India, South Africa, North America, Europe and Australia. The company having primary focus areas in diabetes, arthritis, weight control, depression, cardio vascular and respiratory with 7 brands in top 100.
The firm also have numerous FDA approved bulk facilities. It acquired south African company in 2013 and named as Cipla-Medpro. It has more than 10,000 colleagues and 7 million chemists. Cipla believes that it not only produces medicines but makes difference in patients’ lives. Received Thomson Reuters India innovation award in 2012.
The formulation pipeline has equipped with more than 250+ complex products and with state of art facility for the development of innovative technological products. Developing the products with upcoming technologies like QBD (Quality by design) principles enabling robust and reproducible products in the market. Cipla Biotech, stempeutics (in the area of osteoarthritis) and CIPTEC discovery engine are the new ventures of the company.
About the Job :
Experience : 4+ years of experience in R&D with masters in pharmacy
Job Role :
Must Gather data from pre-formulation studies by carrying out characterization of reference product and optimize the formula in order to develop a robust product
Able to Provide deficiency response support by generating data at R&D/Unit required for approval of the product
need to Collate and review Pharma literature from USFDA etc. in order to utilize knowledge during product development
Provide indent through supply chain management to procure the Filters, RM and PM required during product development and submission batches
should Provide and submit all stage gates documents to CFT on the basis of data generated from development trials to execute batches at plant
Supporting in regulatory submission data by conducting R&D trials and executing regulatory submission batches at the unit for successful filing